EGFR and lung adenocarcinoma: Remarkably, the patients in the GSE31210 cohorts showed a higher EGFR mutation rate (61%) compared to the TCGA cohort (11%), which is consistent with the Asians with higher EGFR mutation rates in lung adenocarcinoma such as the GSE31210 cohort conducted in Japan [51].